ZNF692 and cancer: The results presented in Figure 2C indicate a statistically significant correlation between ZNF692 expression and disease-specific survival (DSS) outcomes in several cancer types, including ACC (p = 0.0004), COAD (p = 0.0084), KIRC (p = 0.0005), and LIHC (p = 0.0166).